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Postnatal b-cell maturation is associated with
islet-speciﬁc microRNA changes induced by
nutrient shifts at weaning
Ce´cile Jacovetti1, Scot J. Matkovich2, Adriana Rodriguez-Trejo1, Claudiane Guay1 & Romano Regazzi1
Glucose-induced insulin secretion is an essential function of pancreatic b-cells that is partially
lost in individuals affected by Type 2 diabetes. This unique property of b-cells is acquired
through a poorly understood postnatal maturation process involving major modiﬁcations
in gene expression programs. Here we show that b-cell maturation is associated with changes
in microRNA expression induced by the nutritional transition that occurs at weaning.
When mimicked in newborn islet cells, modiﬁcations in the level of speciﬁc microRNAs
result in a switch in the expression of metabolic enzymes and cause the acquisition
of glucose-induced insulin release. Our data suggest microRNAs have a central role in
postnatal b-cell maturation and in the determination of adult functional b-cell mass. A better
understanding of the events governing b-cell maturation may help understand why some
individuals are predisposed to developing diabetes and could lead to new strategies for the
treatment of this common metabolic disease.
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P
ancreatic b-cells are the key cell type governing blood
glucose homeostasis thanks to their ability to sense
changes in nutrient levels and their capacity to adapt
the amount of insulin they secrete to match metabolic needs1,2. b-
cell glucose responsiveness is achieved through tight coupling of
insulin exocytosis with glycolysis and mitochondrial metabolism1.
These unique b-cell properties are acquired during a postnatal
maturation process. Indeed, in newborn infants plasma insulin
levels are increased by amino acid administration but
glucose infusion is ineffective in stimulating insulin release3,4.
Numerous studies in rodents have conﬁrmed the absence of
glucose-stimulated insulin secretion in newborn b-cells, despite
normal insulin content and appropriate ion channel activities5–9.
The immature newborn b-cell phenotype is linked to the
presence of strikingly low levels of most glycolytic enzymes and
mitochondrial shuttles10–12 and, concomitantly, to the expression
of the anaerobic glycolytic enzymes Mct1 and Ldha, which are
almost absent in mature b-cells13.
Another feature of newborn b-cells is their strong replicative
potential that allows a signiﬁcant postnatal b-cell mass expansion14.
In humans, the greatest proliferation rate is observed before
2 years of age, and after the age of 5 years the mass of b-cells
remains relatively constant15,16. Thus, the neonatal proliferative
wave is critical for achieving an appropriate adult b-cell mass and
differences in the magnitude of this effect are likely to contribute to
inter-individual diabetes susceptibility17,18.
The suckling–weaning transition is associated with a drastic
nutritional shift in which fat-enriched maternal milk is
replaced by a carbohydrate-rich diet. This requires extensive
and coordinated metabolic adaptations to maintain energy
homeostasis19,20, potentially affecting b-cells. Indeed, glucose is
vital for postnatal b-cell development and diet composition has
been suggested to inﬂuence postnatal b-cell differentiation21–24.
However, the contribution of weaning itself to the acquisition of
the mature b-cell phenotype and the mechanisms potentially
linking the two events remain to be established.
MicroRNAs (miRNAs) are translational repressors that play
key roles in the control of b-cell activities and in diabetes
pathogenesis25,26. Deletion of Dicer1, the enzyme required for
miRNA processing, in Pdx1-expressing cells results in pancreatic
agenesis, while its deletion in insulin-producing cells causes
impaired glucose homeostasis and adult diabetes onset27–30.
Notably, the absence of Dicer1 in Ngn3-expressing cells does not
perturb endocrine cell speciﬁcation during fetal development but
leads to the loss of b-cells and severe metabolic disturbances
during the postnatal period31. Taken together, these observations
point to a critical role for miRNAs in b-cell differentiation.
The aim of this study was to perform a systematic analysis of
miRNA expression changes during postnatal b-cell maturation
and to assess their contribution to the acquisition of a
functionally mature phenotype. Our data demonstrate that the
changes in miRNA expression and the maturation of newborn
b-cells are largely driven by the nutritional transition that occurs
at weaning. Identiﬁcation of key miRNAs involved in b-cell
maturation will help to design therapeutic strategies based on the
engineering of functionally competent insulin-secreting cells and
will shed new light on possible causes of individual diabetes
susceptibility.
Results
Phenotypic properties of newborn b-cells. Pancreatic b-cells
achieve a fully differentiated phenotype only after completion of a
postnatal maturation process. The cellular composition of
newborn rat islets is similar to that of adult animals with a
slightly larger a-cell mass (Supplementary Fig. 1a,b). Ten-day-old
rat b-cells display insulin content and basal insulin secretion
comparable to those of adult b-cells (Fig. 1a,b). In addition,
newborn and adult b-cells show a similar secretory
response to 10mM leucine (Fig. 1a). However, glucose-induced
insulin secretion, an exclusive property of mature b-cells, is
lacking in newborn b-cells (Fig. 1b) and these cells exhibit a
replicative capacity ﬁve times higher than adult b-cells (Fig. 1c).
In contrast, the apoptotic rate is not signiﬁcantly different
(Fig. 1d).
Analysis of islet gene expression by microarray revealed that
postnatal maturation is associated with the upregulation of 2,001
and the downregulation of 1,691 mRNAs (fold change Z2.0,
P-value adjusted for multiple comparisons r0.05). The
transcriptomic modiﬁcations are fully consistent with the
phenotypic changes occurring during newborn b-cell maturation.
Indeed, pathway analysis of the induced genes revealed
enrichment of genes participating in insulin secretion and in
the development of Type 2 diabetes (Fig. 1e). In contrast, the
downregulated genes were preferentially involved in cell cycle,
DNA replication and in amino acid and fatty acid metabolism
(Fig. 1f). Using the same criteria of fold change and
adjusted P-values, together with speciﬁcation of a minimum
abundance level for conﬁdent mRNA detection (see Methods),
high-throughput RNA-sequencing of an independent set of islets
revealed upregulation of 353 and downregulation of 575 mRNAs.
Pathway analysis reached similar conclusions as for the
microarray data. Quantitative PCR (qPCR) analysis of selected
mRNAs, using a further independent set of islets, validated
the ﬁndings of the array and sequencing platforms. All RNAs
considered further in these studies exhibited differential
expression in at least two of these three assays. Overall,
integration of the gene expression changes identiﬁed by distinct
methodologies revealed modiﬁcations in the expression of
components of the same or of closely related pathways,
including the enrichment of key genes involved in glycolysis
(Supplementary Figs 2–5 and Supplementary Tables 1–4).
To determine whether miRNAs might contribute to the switch
in gene expression programs, we compared the level of these
small non-coding RNAs in islets of newborn (10-day-old) and
adult rats (Fig. 1g). We detected 311 miRNAs and found that 68
of them displayed expression changes larger than twofold during
b-cell maturation. Of these, 30 were upregulated and 38
downregulated in adult islets (Supplementary Table 5). As for
mRNAs, similar results were obtained when an independent
set of newborn and adult islet samples were analysed by small
RNA-sequencing. The differences in expression of many of these
miRNAs were conﬁrmed by qPCR, both in rat and mouse islets
(Table 1). Moreover, real-time PCR measurements in highly
puriﬁed b-cells obtained by ﬂuorescence-activated cell sorting
(FACS) conﬁrmed that the changes of most of these
miRNAs occur in insulin-secreting cells (Supplementary Fig. 6).
We found that several of the differentially expressed miRNAs
belong to clusters of miRNAs that are generated from adjacent
genomic loci, potentially from polycistronic precursors, or
because of sequence similarity are classiﬁed into miRNA ‘families’
(Supplementary Figs 7,8). Of note, members of the miR-17/92
and miR-106b/25 clusters as well as miR-215/194 and miR-192/
194 clusters share the same seed sequence and are thus also
classiﬁed as ‘families’ likely to have overlapping targets
(Supplementary Figs 7,8). These groups of miRNAs are therefore
ideally suited to coordinate the modiﬁcations in gene expression
programs taking place during postnatal b-cell maturation.
Based on these observations, we selected for further analysis the
miRNAs belonging to these clusters as well as a further group of
individual miRNAs showing dramatic changes between newborn
and adult islets (Table 1).
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Weaning drives microRNA changes and b-cell maturation. We
examined the kinetics of the modiﬁcations in miRNA expression
by measuring levels of selected miRNAs at different time points
during early postnatal life. We found that the majority of the
modiﬁcations in miRNA expression occur between the 20th (P20)
and the 31st (P31) postnatal day. In particular, the levels of
miR-17-5p, miR-92a-3p, miR-194-5p and miR-129-5p are
signiﬁcantly modiﬁed at P23 (Fig. 2a,e,j,p) and altered levels of
miR-18a-5p, miR-19b-3p, miR-20a-5p, miR-93-5p, miR-106b-5p,
miR-181b-5p, miR-29b-3p and miR-204-5p reach signiﬁcance at
P31 (Fig. 2b–d,g,h,m,o,q). The expression of other miRNAs (miR-
25-3p, miR-192-5p, miR-215, miR-130b-3p and miR-203a-3p)
follow a different expression pattern (Fig. 2f,i,k,l,n). As expected,
miRNAs belonging to the same genomic cluster displayed similar
expression changes but, in some cases, with different kinetics. The
modiﬁcations in miRNA proﬁles are speciﬁc to pancreatic islets
and differ from those occurring during the same postnatal period
in liver, muscle or brain (Supplementary Fig. 9).
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Figure 1 | Phenotypic and transcriptomic differences between 10-day-old and adult rat islets. (a) Insulin content (left panel) and insulin release (right
panel) after 45min exposure in the presence or absence of 10mM leucine (n¼ 3–4). (b) Insulin content (left panel) and insulin secretion (right panel) after
45min exposure to 2 or 20mM glucose (n¼ 3–4). (c) b-cell proliferation quantiﬁed by determining the percentage of insulinþ (insþ ) and Ki67þ cells
(n¼ 3). (d) b-cell death assessed by scoring the percentage of insulinþ (insþ ) cells labelled with TUNEL (n¼ 3). All data are presented as means±s.d. as
determined by ANOVA. *Po0.05, **Po0.01, ***Po0.001, ****Po0.001 (a–d). (e,f) Selected KEGG pathways upregulated (e) and downregulated (f) in adult
rat islets. The bars show the Enrichment score ( log10 (P-value)) of the pathways in our data set. Modiﬁed Fisher’s exact test (EASE cutoff Po0.05) was
used to estimate the false discovery rate (FDR) and the thresholds to select signiﬁcantly enriched KEGG pathways. (g) Scatter plot shows differentially
expressed miRNAs between newborn and adult rat islets (Po0.05). Selected miRNAs up- and downregulated in adults are highlighted (n¼4).
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Our observations situate the critical period for the changes in
islet miRNA expression near the time of weaning, which in rats
takes place at P21. We reasoned that these processes may
be driven by the drastic diet shift caused by the completion of
a transition from maternal milk, rich in fat and proteins, to a
carbohydrate-rich chow diet. To investigate this hypothesis, we
weaned a group of rats at P15 and fed them with a starch-based
diet. No signiﬁcant weight loss was detected in prematurely
weaned animals, ruling out the possibility of confounding
effects linked to an eventual starvation of the pups
(Supplementary Fig. 10). Remarkably, in animals subjected to
early weaning (EW) with chow diet rich in carbohydrates the
changes in the level of most miRNAs were accelerated
compared to rats weaned at P21 (normal weaning: NW). Indeed,
miR-17-5p, miR-18a-5p, miR-19b-3p, miR-20a-5p, miR-92a-3p,
miR-93-5p, miR-106b-5p, miR-194-5p and miR-181b-5p are
already reduced at P20 in EW pups (Fig. 3a–e,g,h,j,m); however,
the upregulation of miR-29b-3p, miR-129-5p and
miR-204-5p observed at the end of the postnatal period is lower
in EW pups (Fig. 3o–q). Importantly, the expression pattern of
miRNAs not observed to change near weaning time is not
modiﬁed in animals prematurely withdrawn from the mother
(Fig. 3f,i,k,l,n).
To assess whether the changes in miRNA expression correlate
with the acquisition of a mature secretory phenotype, we
measured insulin release from the islets of the same animals.
We found that in rats weaned normally at P21 the capacity to
secrete insulin in response to 20mM glucose coincides with the
changes in miRNA expression and is fully achieved at P23
(Fig. 4a). In contrast, insulin content, basal secretion and
leucine-stimulated insulin secretion remained constant from
P10 to adults (Supplementary Fig. 11a,b). Moreover, changes in
miR-17-5p, miR-106b-5p and miR-129-5p were correlated with
the acquisition of glucose responsiveness during the postnatal
period (Supplementary Fig. 12). Interestingly, premature weaning
accelerated the acquisition of glucose-induced insulin secretion,
with the typical response of P23 islets in NW observed as early as
P20 (Fig. 4b). Again, basal insulin secretion, leucine-stimulated
insulin secretion and insulin content were not affected by
EW (Supplementary Fig. 11c,d) but the inverse correlation of
miR-17-5p and miR-106b-5p with glucose responsiveness was
even stronger in EW (Supplementary Fig. 12) and miR-181b-5p,
which did not signiﬁcantly decrease from P15 to P23 in NW,
displayed a signiﬁcant negative correlation to glucose
responsiveness in EW. Taken together, our observations suggest
that both islet miRNA changes and the acquisition of the
capacity to secrete insulin in response to glucose are driven by
the dietary shift associated with weaning. Analysis of b-cell
replication at the same time points revealed a progressive decline
from P10 to P20. The proliferation rate then remained stable
until P31 without reaching the very low level observed in adult
b-cells (Supplementary Fig. 13). The kinetics of altered b-cell
proliferation were not modiﬁed in prematurely weaned animals.
To assess whether the shift in diet composition is directly
affecting the acquisition of glucose-induced insulin secretion, a
group of newborn rats was weaned at P15 but was maintained on
a high-fat diet (HFD). We found that in these animals the
typical acquisition of glucose-induced insulin secretion at P23 was
prevented (Fig. 4c). The effect of the diet persisted at least
until P47 but was reversed if the animals were switched on a
chow diet (Fig. 4d). Indeed, a group of rats initially weaned with
a HFD but fed with a chow diet from P31 was able to release
insulin in response to glucose as well as age-matched animals
constantly maintained on a carbohydrate-rich diet (Fig. 4d).
Moreover, the changes in islet miRNA levels normally occurring
upon a shift to a carbohydrate-rich diet were prevented in
animals prematurely weaned on a HFD (Fig. 5). Taken together,
these data demonstrate that the shift from a fat-enriched diet to
carbohydrate-enriched diet occurring during weaning plays an
important role in the capacity of islets to release appropriate
insulin in response to nutrient supply.
miRNA changes initiate postnatal b-cell maturation. We next
analysed the functional role of the miRNAs displaying expression
modiﬁcations in the postnatal life and studied their involvement
Table 1 | Islet microRNA expression changes assessed by microarray and qRT-PCR between newborn and adult rat and mouse
islets.
Microarray from rat islets qRT-PCR from rat islets qRT-PCR from mouse islets
microRNA Fold change adult
vs P10
Adjusted P-value
(FDR)
Mean P10
Log2
Mean adults
Log2
Fold change adult
vs P10
P-value Fold change adult
vs P10
P-value
miR-17-5p 4.2 2.28e04 8.01 5.94  3.5 1.93e02  3.5 2.62e02
miR-18a  3.7 1.97e04 6.44 4.56  3.5 4.92e02  2.6 1.71e02
miR-19b 4.5 5.98e04 11.30 9.13  3.6 3.79e03  3.8 5.90e03
miR-20a  3.6 3.65e04 9.50 7.64 4.1 1.89e02  2.8 3.28e02
miR-92a 4.3 4.47e03 10.43 8.31  7.3 3.41e02 6.3 2.14e02
miR-25  2.3 8.46e03 10.00 8.81  1.9 6.45e04  11.4 2.07e02
miR-93  2.9 2.67e04 8.48 6.97  2.3 3.60e02 4.1 1.33e02
miR-106b  2.2 5.11e04 10.96 9.79  3.2 2.02e02  10.1 2.01e02
miR-192 6.8 1.37e02 10.85 8.09  5.0 5.00e02  1.7 3.72e03
miR-194 9.5 8.70e03 10.16 6.91 4.2 2.54e02  1.3 2.68e02
miR-215  139.2 5.82e04 9.62 2.50  112.9 2.44e03  2.0 1.79e01
miR-130b  5.3 8.92e04 7.96 5.57  5.1 1.23e02  5.4 5.90e03
miR-181b  5.1 3.86e03 7.68 5.35 6.7 2.45e03  2.6 4.74e02
miR-203 6.9 2.58e03 7.60 4.81 6.4 8.85e03  7.6 2.14e01
miR-29b 8.6 2.53e04 10.60 13.71 11.6 4.72e03 14.8 3.95e02
miR-129 5.7 4.60e03 5.86 8.36 3.4 1.35e02 3.7 1.44e02
miR-204 3.8 3.65e04 7.51 9.44 4.5 3.96e02 1.8 1.71e01
FDR, false discovery rate; qRT-PCR, quatitative PCR with reverse transcription.
Relative expression of the 17 selected miRNAs as determined by microarray. The mean expression of each group is presented on a log2 scale and adjusted p-values are the smallest FDR for which the test
can be called ‘signiﬁcant’. Fold changes in miRNA expression as conﬁrmed by qRT-PCR in 10-day-old vs adult rat islets (n¼4) and in 10-day-old vs adult mouse islets (n¼ 3) (Po0.05). For the
microarray data, the P-values were adjusted using the Benjamini–Hochberg method to evaluate the FDR.
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in b-cell maturation. For this purpose, we mimicked the changes
in miRNA expression by transfecting 10-day-old rat islet cells
with oligonucleotides that either block (anti-miRs) or increase
(miRNA mimics) the level of the miRNAs (Supplementary
Fig. 14a,b). We ﬁrst assessed whether the modiﬁcations in
miRNA expression affect insulin biosynthesis and secretion.
Manipulation of selected miRNAs did not modify insulin content
(Supplementary Fig. 15a-e), basal secretion (Fig. 6a–e) or leucine-
stimulated insulin release (Supplementary Fig. 16a–e). However,
when the postnatal maturation process was mimicked by redu-
cing the level of miR-17-5p, miR-25-3p, miR-106b-5p, miR-194-
5p, miR-181b-5p or by increasing the level of miR-129-5p
(previously shown in Fig. 2), newborn b-cells acquired the
capacity to release insulin in response to glucose (Fig. 6a–e). In
contrast, changes in levels of the other miRNAs in these families
were not sufﬁcient to promote glucose responsiveness in newborn
b-cells (Fig. 6a–e). Beside favouring the acquisition of a mature
secretory phenotype, the reduction of miR-17-5p, miR-106b-5p
and miR-181b-5p also resulted in decreased proliferation of
newborn b-cells; reductions of miR-18a-5p and miR-203a-3p did
not affect secretion but decreased proliferation (Fig. 6f,g,i).
The other miRNAs had no impact on newborn b-cell replication
(Fig. 6f-j) except for the increase of miR-129-5p that increased
it further (Fig. 6j). The effects of individual miRNAs on
glucose-induced insulin secretion and b-cell proliferation
were not further ampliﬁed when all the miRNAs belonging to
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Figure 2 | Weaning-dependent islet miRNA changes. qRT-PCR were performed using islet RNAs of rats from the indicated ages. miRNA levels were
normalized to U6 and expressed in fold change (n¼4–6 per group). The bars of miRNAs belonging to the same cluster are highlighted with the same
shading. The bars of miRNAs that are not members of clusters are in white. Data are means±s.d. Statistical difference from P10 miRNA levels was
assessed by one-way ANOVA with a Dunnett post-hoc test: *Po0.05, **Po0.01, ***Po0.001, ****Po0.0001.
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miR-17/92, miR-106b/25, miR-215/194 or miR-192/194 clusters
were simultaneously reduced (Supplementary Fig. 17), suggesting
that we had identiﬁed the most functionally important
members of these clusters. Altogether, these data suggest that
changes in the miRNA proﬁle are instrumental in driving the
acquisition of the mature b-cell phenotype. We then assessed
whether fully functional adult b-cells could be reversed to an
immature phenotype by modulating the same miRNAs. For this
purpose, adult b-cells were transfected with miRNA mimics or
anti-miRs to restore miRNAs to levels observed in newborn
rats (Supplementary Fig. 14c,d). We found that except for the
overexpression of miR-106b-5p, which led to a partial loss
of glucose-induced insulin secretion (Fig. 6k), restoration of
newborn levels of the other miRNAs did not have an impact on
glucose-stimulated insulin release (Fig. 6k,l). Insulin content
(Supplementary Fig. 15f,g) and insulin secretion under basal
conditions (Fig. 6k,l) or in response to leucine (Supplementary
Fig. 16f,g) were not altered. Overexpression of miR-17-5p and
miR-181b-5p resulted in a 2-fold increase in the number
of proliferating adult insulin-positive cells (Fig. 6m) whereas
modiﬁcations in the level of the other miRNAs did not impact on
adult b-cell replication (Fig. 6m,n). These ﬁndings suggest that
the changes in miRNA expression observed in early postnatal life
can drive the ﬁnal differentiation of b-cells only in the particular
gene expression context encountered in newborn b-cells.
miRNAs drive expression of key genes for b-cell maturation.
To determine the mechanisms through which the differentially
expressed islet miRNAs contribute to postnatal b-cell maturation,
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we delineated changes in gene expression speciﬁc to manipulation
of individual miRNAs. In view of the functional effects observed
when miR-17-5p, miR-106b and miR-181b are reduced in
newborn islet cells on both, glucose responsiveness and cell
proliferation, we examined whether relevant target genes
controlling metabolism and cell replication predicted by
miRSystem32 and miRWalk33 algorithms were upregulated upon
their inhibition (Supplementary Table 6). We found
that blockade of miR-17-5p resulted in the upregulation of
phosphofructokinase (Pfkp), transforming growth factor
b receptor 2 (Tgfbr2), Smad4, phosphatase and tensin
homolog (Pten), TIMP metallopeptidase inhibitor 2 (Timp2),
cyclin-dependent kinase inhibitor 1A (p21; Cdk1a) and
retinoblastoma-like 2 (p130; Rbl2) (Fig. 7a,d). Despite sharing
the same seed sequence, miR-106b-5p did not trigger the same
expression changes as miR-17-5p and none of the genes tested
was signiﬁcantly modiﬁed upon its blockade (Fig. 7b,e). To test
whether these genes are direct targets of miR-17-5p, luciferase
constructs containing their 30UTR sequences were co-transfected
in the insulin-secreting cell line INS832/13 with a miR-17-5p
mimic. We found that the expression of Pfkp, Tgfbr2 and Pten
constructs was indeed reduced by 50–70% upon miR-17-5p
overexpression (Fig. 7g). Inhibition of miR-181b-5p resulted in
increased expression of glycerol-3-phosphate dehydrogenase
2 (Gpd2), malate dehydrogenase 1 (Mdh1), sirtuin 1 (Sirt1) and
transforming growth factor b receptor 1 (Tgfbr1) (Fig. 7c,f).
Using a luciferase reporter assay, we indeed conﬁrmed that Gpd2,
Mdh1 and Sirt1 are direct targets of miR-181b (Fig. 7h).
Consistent with the previous ﬁndings, we found that the levels
of miR-17-5p and its targets Pfkp and Pten (Fig. 7i,j) and the
levels of miR-181b-5p and those of Gpd2 and Mdh1 (Fig. 7k,l) are
inversely correlated throughout the postnatal maturation
process. No signiﬁcant correlation was found for the other
predicted mRNA targets of miR-17-5p or miR-181b-5p. Thus,
downregulation of miR-17-5p and miR-181b-5p allow the
expression of key metabolic enzymes and cell cycle regulators,
reproducing the events occurring during postnatal b-cell
maturation.
The most substantially upregulated miRNA during postnatal
maturation was miR-29b-3p (Fig. 2o), although its overexpression
did not affect glucose-induced insulin secretion (GSIS) acquisition
or inhibit b-cell proliferation in the same manner as upregulated
miR-129-5p (Fig. 6). Nonetheless, we observed a downregulation
of the level of several predicted targets for miR-29b-3p
(Supplementary Table 7). Indeed, when we reproduced the
overexpression of miR-29b-3p occurring during postnatal b-cell
maturation in 10-day-old rat islets we observed a striking
reduction in the expression of the transcription factor Rest, and
of Mct1 and Pdgfra (Fig. 7m). Consistently, overexpression of
miR-29b inhibited by about 50% the expression of luciferase
constructs carrying the 3’UTR of Pdgfra and Rest, conﬁrming a
direct interaction with the miRNA (Fig. 7n). The increase of
miR-29b-3p in islets throughout the postnatal period, was also
negatively correlated with the repression of Mct1, a previously
identiﬁed direct target of miR-29b34 (Fig. 7o). Low expression of
Mct1 is a key feature of mature b-cells, which prevents pyruvate
entry into the TCA cycle from lactate conversion and is thought to
prevent consequent ‘short-circuiting’ of glucose-dependent ATP
production that triggers GSIS. Taken together, these experiments
provide an initial explanation for the molecular mechanisms
causing the phenotypic modiﬁcations occurring during the
maturation of b-cells.
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Figure 4 | Impact of weaning time and diet composition on b-cell maturation. Insulin secretion in the presence of 2 or 20mM glucose in islets isolated
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Downstream signalling elicited by miR-17-5p modiﬁcation.
We focused on miR-17-5p that appeared to control a large
number of mRNA expression modiﬁcations, and overexpressed
it in P10 islet cells (Supplementary Fig. 18). To empirically
identify direct mRNA targets, we used the unbiased approach
of Ago2 immunoprecipitation and subsequent RNA-sequencing
of both the Ago2 and global mRNA fractions35. Firstly, at
the global mRNA level, miR-17-5p overexpression altered the
abundance of 309 mRNAs (false discovery rate r0.1) that had
also passed detection criteria in the prior comparisons of adult
and P10 islets. 185 of these mRNAs (60%) were altered in the
opposite direction in adult vs P10 islets (false discovery
rater0.1), in which miR-17-5p expression is decreased, and a
further 64 mRNAs (21%) were altered in the opposite direction in
adult vs P10 islets but did not reach statistical signiﬁcance
(Supplementary Data 1). Bioinformatic analysis conﬁrmed the
enrichment of genes involved in cell proliferation, TGFb
signalling pathway and cell growth as previously observed by
quatitative PCR with reverse transcription (qRT-PCR)
(Supplementary Data 2). Thus, a change in miR-17-5p alone
was able to recapitulate a substantial fraction of the differences in
gene expression observed between adult and P10 islets. Secondly,
to identify direct mRNA targets of overexpressed miR-17-5p, we
searched for mRNAs whose abundance increased in the Ago2
immunoprecipitate (RISC fraction), with either a parallel decrease
in the global mRNA fraction or no signiﬁcant change in global
mRNA (indicating RISC-mediated transcript degradation or
translational suppression, respectively). One hundred thirteen
mRNAs were thus deﬁned as putative direct targets of miR-17-5p
in P10 islets (Supplementary Data 3). Bioinformatic analysis
showed an increased RISC incorporation of transcripts involved
in cell cycle regulation (Supplementary Table 8), similarly to
those mRNAs altered without direct RISC involvement
(Supplementary Data 1). Taken together, these data show that
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Figure 5 | Impact of diet composition on miRNA expression changes. qRT-PCR were performed using islet RNAs of rats from the indicated ages in rats
weaned at P15 with a carbohydrate-rich chow diet (black bars) or with a high-fat diet (grey bars). miRNA levels were normalized to U6 and expressed in
fold change. Data are means±s.d. Statistical differences were assessed by one-way ANOVA with a Dunnett post-hoc test: *Po0.05.
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we have identiﬁed direct, translationally suppressed mRNA
targets of miR-17-5p through RISC association experiments,
together with a number of putative direct targets of miR-17-5p
using target prediction algorithms, miRNA inhibition and mRNA
measurements. Overall, regardless of direct or indirect control of
these mRNAs by miRNAs, we have identiﬁed critical mRNAs that
respond to miRNA reprogramming and that likely contribute to
the shift in gene expression programs needed for postnatal b-cell
maturation and acquisition of the distinct functional identity of
adult islets (Fig. 8).
Discussion
MiRNAs are important players in the onset of chronic metabolic
diseases such as diabetes. These non-coding RNAs are central
actors in the embryonic differentiation of insulin-producing cells
and in the control of mature b-cell activities25,36 but, so far, no
information has been available about their possible contribution to
postnatal b-cell maturation, a critical process for the acquisition of
adult b-cell function. A better understanding of the mechanism
driving this essential process will be instrumental for the design of
cell-based strategies for the treatment of diabetes.
In agreement with previous reports8,9,37,38, we detected marked
phenotypic differences between 10-day-old and adult rat b-cells;
in particular, an absent secretory response to increased glucose
levels and higher proliferation rates in newborn b-cells.
A recent study carried out in islets from infants suggests that
analogous functional differences may exist in humans39. We
found that the phenotypic characteristics of newborn b-cells are
linked to a very low expression of genes involved in insulin
secretion and glucose metabolism and to a marked expression of
genes promoting proliferation and the metabolism of amino acids
and fatty acids. The data obtained in our global transcriptomic
survey corroborate those of previous studies focusing on speciﬁc
metabolic genes and developmentally regulated transcription
factors10,11,13,40–42.
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Figure 7 | miR-17-5p and miR-181b orchestrate the expression of key b-cell genes. P10 islet cells were transfected with antimiR-17-5p (a,d), antimiR-
106b (b,e), antimiR-181b (c,f) or miR-29b (m) (n¼ 3–5). Genes involved in glucose metabolism, insulin secretion and proliferation were selected from the
predicted targets of these miRNAs. The hatched bars highlight the predicted targets for the corresponding miRNAs. mRNA and miRNA levels were
measured by qRT-PCR and are expressed as fold changes (FC) (n¼4). Direct interaction with putative target mRNAs of miR17-5p (g), miR-181b (h) and
miR-29b (n) was validated by luciferase reporter assays in the rat insulin-secreting cell line INS832/13. Vectors containing the 3’UTR of Pfkp, Tgfbr2, Pten,
Gpd2, Mdh1, Sirt1, Pdgfra and Rest were co-transfected with either a control oligonucleotide or oligonucleotides mimicking the miRNAs of interest. The
graphs show the correlations between the mRNA level of the identiﬁed target genes and miR-17-5-p (i,j), miR-181b (k,l), or miR-29b (o). Data are
means±s.d. (n¼ 3) and statistical signiﬁcance were calculated by Student’s t-test: *Po0.05. Correlations were established with Pearson correlation test.
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Systematic analysis of the miRNA proﬁles of newborn and
adult b-cells revealed major differences in the level of these
non-coding RNAs and highlighted selective changes of several
clusters and families of miRNAs. We observed that most of these
changes occur between the 20th and 31st postnatal day and
correlate with the acquisition of b-cell glucose responsiveness.
This critical time window corresponds to the weaning period
when nutritional input is drastically modiﬁed by the replacement
of high-fat maternal milk with a carbohydrate-rich diet.
Our ﬁndings are in agreement with studies that situate the
acquisition of mature b-cell functionality around weaning
time9,24 and that postulate a key role for weaning in
physiologic adaptations19. Interestingly, many of the relevant
changes in miRNA expression and the acquisition of a mature
secretory phenotype take place earlier in newborn rats that are fed
a carbohydrate-rich diet (prematurely weaned) starting from day
15 rather than day 21. These observations are consistent with a
study demonstrating induction of key islet genes involved
in glucose metabolism, increased insulin expression and
hyperinsulinemia in 4-day-old rat pups fed with a high-
carbohydrate milk formula22. The accelerated acquisition of
these phenotypic traits is likely to be part of a metabolic
adaptation that permits maintenance of normoglycemia in the
context of a carbohydrate-rich diet via increased insulin secretion.
In contrast, weaning the rats on a HFD prevented most
miRNA changes and the acquisition of glucose-induced
insulin secretion, suggesting that these events are driven by the
exposure to a carbohydrate-rich diet and the consequent
increase in the insulin needs rather than to a particular
developmental stage. The dietary shift elicits metabolic
adaptations that are likely to extend far beyond changes in
b-cell properties alone. Indeed, after weaning increased hepatic
expression of glycolytic and lipogenic enzymes consequent to a
rise in plasma insulin levels have been reported19,20,43,44. While
speculative, some of these adaptive gene expression changes may
possibly be driven by modiﬁcations in the level of liver miRNAs
detected in our study (Supplementary Fig. 9).
The robust proliferative capacity of newborn b-cells was found
to decline between the 10th and the 20th postnatal day but,
consistent with previous studies in rodents showing continuous
b-cell mass expansion over the ﬁrst month of life45,46,
the replicative rate at P31 was still higher than that observed in
adults and was not affected by premature weaning. Very
recently, Dor and colleagues reported that premature weaning
of mice on a HFD does not affect basal b-cell expansion but
impairs their capacity to proliferate in response to glucose24.
These ﬁndings are fully consistent with those presented here. In
fact, this compensatory, glucose-responsive b-cell mass expansion
is likely to rely on the same glucose sensing mechanisms
controlling insulin secretion that are acquired upon weaning.
In view of these observations, it is tempting to speculate that
some of the miRNAs characterized in the present study may
thus contribute to compensatory b-cell mass expansion in
response to a glucose challenge.
To establish a causal link between the modiﬁcations in the
miRNA proﬁle and the postnatal maturation process, we
experimentally reproduced in newborn islet cells most of the
relevant miRNA changes and scrutinized their impact on
insulin secretion and cell proliferation. Indeed, mimicking the
changes in the level of several miRNAs altered at weaning
(miR-17-5p, miR-25-3p, miR-106b-5p, miR-194-5p, miR-181b-5p
and miR-129-5p) established a premature glucose-induced
secretory response in newborn b-cells. Moreover, manipulating
the level of some miRNAs (miR-17-5p, miR-18a-5p, miR-106b-5p,
miR-181b-5p and miR-203a-3p) reduced the proliferation rate
of immature b-cells, suggesting that the presence of low
amounts of these miRNAs in adult b-cells contributes to their
limited proliferative capacity. These data are consistent with the
roles attributed to several of these miRNAs in studies carried
out in mature b-cells. Indeed, reduction of miR-25-3p was
shown to enhance glucose-induced insulin secretion in adult
b-cells47 and the clusters miR-17/92, miR-106b/25 and
miR-181b-5p were postulated to control b-cell proliferation48,49.
Remarkably, the level of most miRNAs identiﬁed as regulators of
b-cell maturation is reduced, rather than increased, during
postnatal development. This observation supports the fascinating
hypothesis put forward by Rutter and Hornstein groups,
suggesting that a speciﬁc set of miRNAs needs to be disallowed
to achieve proper b-cell maturation34,50. The precise mechanisms
underlying the changes in miRNA expression remain to be
explored. The acquisition of a mature b-cell secretory phenotype
was previously proposed to be driven by increased expression of
the transcription factor Mafa51. Future studies will need to assess
the existence of a possible link between the induction of Mafa or
other transcription factors and switches in miRNA transcription.
In our study, we were able to show that the downregulation of
speciﬁc miRNAs is instrumental for the activation of gene
expression programs culminating in the acquisition of a fully
mature b-cell phenotype. In fact, blockade of miR-17-5p and
miR-181b-5p permitted the expression of several key limiting
enzymes for glucose metabolism such as Pfkp, Gpd2,Mdh1 and of
genes regulating cell proliferation such as Pten, Tgfbr1/2 and
Cdkn1a. Interestingly, Gpd2 and Pfk were both found to be
expressed at lower levels in pancreatic islets of Type 2 diabetic
subjects52,53 and were associated with impaired glucose
metabolism and loss of b-cell function54,55. By identifying key
mRNA regulators of metabolism and b-cell function as direct
targets of miR-17-5p and miR-181b, our data raise the hypothesis
that misregulation of miRNAs (and consequently the expression
of their targets during postnatal life) may predispose individuals
to metabolic disturbances and diabetes onset via interference with
postnatal b-cell mass expansion. miR-29b-3p is among the most
abundant miRNAs present in pancreatic islets56, which we also
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demonstrated in our miR-sequencing data set. The strong
upregulation of miR-29b-3p occurring during the postnatal
maturation process is likely to ensure proper silencing of key
transcription factors such as Rest, which is absent in mature
insulin-producing cells57, and of other factors such as Mct1 and
Pdgfra that belong to a group of genes speciﬁcally disallowed in
adult, fully functional mouse islets13,58,59. Our ﬁndings
demonstrating direct targeting of Rest and Pdgfra complement
a previous report of miR-29b-3p binding to the 3’UTR of Mct1
(ref. 34) and strengthen the hypothesis that this miRNA is an
important factor in programming and maintaining b-cell identity
during postnatal development, although its manipulation in our
studies was not sufﬁcient on its own to provoke alterations in
GSIS acquisition or b-cell proliferation.
In conclusion, this study demonstrates that miRNAs are key
regulators of postnatal b-cell maturation and essential players in
the metabolic adaptation of newborns to changes in nutrient
supply. Our observations suggest that malnutrition during
early life, within a critical time window corresponding to
the completion of endocrine pancreas maturation, may affect
the metabolic reprogramming necessary to the acquisition of a
fully mature b-cell phenotype and to the establishment of an
appropriate b-cell mass. In adulthood, this could potentially have
an impact on the capacity of b-cells to meet conditions of
increased insulin demand such as pregnancy and obesity,
predisposing the affected individuals to the development
of gestational and Type 2 diabetes18,60. A better understanding
of these critical events occurring early in life will help
in elucidating the causes of individual diabetes susceptibility
in the adult.
Methods
Animals. Sprague Dawley rats were obtained from Janvier Laboratories. Animal
experimentation was carried out in Lausanne, Switzerland. All procedures were
performed in accordance with the National Institutes of Health guidelines, and
were approved by the ‘Service de la consommation et des affaires veterinaires’,
Epalinges, Switzerland (authorization VD2608).
Weaning procedure. At birth, litters were adjusted to 10–12 offsprings per dam to
standardize mother milk availability. Newborn pups (males and females) were
nursed until they were killed. At P21 (normal weaning, NW), at P15 (EW) or at
P31, the pups were weaned on a standard chow diet containing 18.5% crude
proteins, 4.5% fat and 54% carbohydrates or on a HFD providing 5.24Kcal g 1,
20% proteins, 60% fat, 20% carbohydrates. Food was crushed and put directly
above bedding for 5 days to ensure food availability to the prematurely weaned rats.
RNA assays. Total RNA was extracted with the miRNeasy kit (Qiagen) except
for mRNA- and miRNA-sequencing for which Trizol was used. For mRNA-
sequencing, each biological replicate was a pool of islets of ﬁve P10 pups or of a
single adult rat. For microarray analysis and real-time PCR, pancreatic islets from
two P10 pups were pooled while islets from P15, P20, P23, P31, P47 and adult rats
were extracted individually. For qPCR measurements, islets from either ﬁve to
seven pups or from two adult rats were pooled. miRNA proﬁling was performed at
the Genomic Technologies Facility of the University of Lausanne using Agilent
Technologies miRNA Gene Microarrays. mRNA proﬁling was performed by
Arraystar using Agilent Technologies and data analysis was performed using
Agilent GeneSpring GX v11.5.1 software. For mRNA-sequencing the RNA was
converted into a library of template molecules for Illumina single-end sequencing
as previously described35. miRNA-sequencing was performed from the same input
RNA samples, using the Illumina TruSeq small RNA-sequencing kit as previously
described61. miRNA- and mRNA-sequencing was performed at Washington
University GTAC (indexed Illumina single-end, 50 nt sequencing on a HiSeq 2500
instrument) and analyses of raw read data performed as previously described62.
miRNA abundances from sequencing analyses are presented as Reads per million
reads mapped to miRNAs; mRNA abundances are presented as FPKM (Fragments
Per Kb of exon per Million reads mapped to mRNAs). However, differential
expression was calculated using raw read counts as input to DESeq (see Statistics).
Biological function and pathway analyses were performed using DAVID63.
Mature miRNA and mRNA levels were assessed by qRT-PCR using the
miScript II RT kit (Qiagen). miScript primer assays and primer sequences are
provided in Supplementary Table 9. miRNA expression was normalized to the level
of U6. mRNA expression was normalized to the amount of 18S rRNA.
Cell culture. Pancreatic islets were isolated by collagenase (Roche) digestion64 and
puriﬁed on a Histopaque (Sigma-Aldrich) density gradient. They were cultured in
RPMI 1640 Glutamax medium (Invitrogen, Carlsbad, CA, USA) supplemented
with 10% fetal calf serum (Amimed), penicillin 50Uml 1, streptomycin
50 mgml 1, Na Pyruvate 1mM and 250 mmol l 1 Hepes.
Cell transfection. Transfection of dissociated rat islet cells with miScript miRNA
inhibitors (anti-miR) (Qiagen) or with oligonucleotide duplexes (Eurogentec) was
performed using Lipofectamine 2000 (Invitrogen) as previously described65.
Fluorescence-activated cell sorting (FACS). Dissociated islet cells from newborn
and adult rats were sorted by FACS based on b-cell autoﬂuorescence, as previously
described66. Purity of sorted b-cells was evaluated by immunocytochemistry using
insulin (Dako: #A0564) and glucagon (Abcam: #ab10988) antibodies. Our FACS
contained on average 94±1% b-cells and 3–4% of a-cells.
Insulin secretion. Whole islets and dissociated rat islet cells were preincubated
with KREBS buffer (127mM NaCl, 4.7mM KCl, 1mM CaCl2, 1.2mM KH2PO4,
1.2mM MgSO4, 25mM HEPES, 5mM NaHCO3) containing 2mM of glucose
(basal condition) during 30min at 37 C. The medium was then replaced by either
the same buffer (basal condition) or a KREBS buffer supplemented with 20mM of
glucose (stimulatory condition). After 45min, the supernatants were collected and
cellular insulin contents were recovered in EtOH acid (75% EtOH, 0.55% HCl).
The amount of insulin in the samples was determined by ELISA (Mercodia).
Immunocytochemistry. Dissociated rat islet cells were plated on poly-L-lysine-coated
glass coverslips. The cells were ﬁxed in cold methanol and incubated with phosphate-
buffered saline supplemented with 0.5% saponin (Sigma-Aldrich) for 15min. After
30min incubation in blocking buffer (phosphate-buffered saline supplemented with
0.5% saponin and 1% bovine serum albumin), the cells were incubated for 1 h at room
temperature with primary antibodies at the following dilutions: 1:1,300 rabbit
anti-Ki67 (Abcam: #ab15580); 1:500 guinea pig anti-insulin (Abcam: #ab10988). The
coverslips were then incubated during 1h at room temperature with goat anti-rabbit
Alexa-Fluor-488 and goat anti-guinea pig Alexa-Fluor-555 diluted at 1:400 (Invitro-
gen: # A11008 and # A21435. respectively). Before being mounted on microscope glass
slides using FluorSave mounting medium (VWR International SA) the coverslips were
treated for 10min at room temperature with Hoechst 33342 (Invitrogen). The cells
were visualized with a Zeiss Axiovision ﬂuorescence microscope.
Immunohistochemistry. Animals were killed and the pancreases ﬁxed in 10%
neutral buffered formalin (Sigma-Aldrich) for 24 h and embedded into parafﬁn for
sectioning. The slices were stained using the following primary antibodies: 1:500
rabbit anti-Ki67 (Abcam: # ab15580), 1:200 guinea pig anti-insulin (Abcam:
# ab7842), 1:200 rabbit anti-glucagon (Abcam: # ab10988). Goat anti-rabbit Alexa-
Fluor-488, goat anti-guinea pig Alexa-Fluor-555 and goat anti-mouse Alexa-Fluor-
555 diluted at 1:400 (Invitrogen: # A11008, # A21435 and # A21422, respectively)
were used as secondary antibodies. TUNEL staining was performed using the In Situ
Cell Death Detection Kit (Roche). Cell nuclei were visualized with Hoechst 33342.
Images were collected using a Zeiss Axiovision ﬂuorescence microscope.
Luciferase assays. Luciferase reporter plasmids were generated by cloning about
200 nucleotides of the 30UTR of rat Pfkp, Tgfbr2, Pten, Gpd2, Mdh1, Sirt1, Pdgfra
and Rest, containing the putative binding sites of miR-17-5p, miR-181b or
miR-29b. Luciferase activity was measured in INS832/13 cells with a dual-luciferase
reporter assay (Promega, Madison, WI, USA) 3 days after transfection. Renilla
luciferase activity was normalized for transfection efﬁciency to the SV40-driven
Fireﬂy activity generated from a co-transfected PGL3 promoter vector (Promega).
Ago2 immunoprecipitation and RISC-sequencing. Ago2 immunoprecipitation
and preparation and sequencing of RNA libraries from RISC fractions were
performed as described35,67. Raw read analysis was carried out as described62.
Biological function and pathway analyses were performed using DAVID63.
Statistics. Values are expressed as mean±s.d. Statistical analysis was performed
using one-way ANOVA with Dunnett’s post-hoc test for multiple comparisons or
two-way ANOVA with Tukey’s post-hoc test for multiple comparisons. Student’s
t-test was used for unpaired comparisons. P-values were adjusted by the Benjamini–
Hochberg method, controlling for false discovery rate for the miRNA microarray.
Correlation coefﬁcients and signiﬁcance were derived from Pearson rank correlation
test. Differential expression from sequencing reads were computed on read count
data using the DESeq package in R (ref. 68) as previously described62. miRNAs with
an abundance o10 RpM in more than 50% of samples were designated as ‘below
read cutoff’. Similarly, mRNAs whose reads represented o1/100,000th of the total
reads were ﬁltered out, leaving B7,300 mRNAs for further analysis.
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